While the data is promising, it is crucial to remember that Retatrutide is still in Phase 3 development and is not yet commercially available
Furthermore, studies should explore the optimal dosing and duration of GLP-1RA therapy to maximize cardiovascular benefits while minimizing potential adverse effects
Eight patients in the metformin group discontinued the study prematurely: 1 patient due to dyspepsia, 2 due to fatigue, 2 due to a lack of perceived efficacy, 2 due to worsening psychiatric symptoms and a consequent change of psychotropic medication, and 1 due to substance abuse
Despite new research linking GLP-1 drugs to NAION, manufacturers have not updated the product labels to reflect this danger
Quality of life measures also improved after GLP-1 treatment
How does a type 2 diabetes treatment aid in weight loss